15213-88-4

Usage

InChI:InChI=1/C10H16N2O8.Gd/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);/q;+3/p-4

Upstream product

• 15158-67-5 (cerium(III)ethylenediaminetetraacetate)(1-) 
• 22541-19-1 gadolinium(III) 
• 15009-39-9 Nd⁽³⁺⁾*OOCCH₂(OOCCH₂)NCH₂CH₂N(CH₂COO)2^(4-)=Nd(OOCCH₂)2NCH₂CH₂N(CH₂COO)2^(1-) 
• 10138-52-0 gadolinium(III) chloride 
• 60-00-4 ethylenediaminetetraacetic acid 
• 221468-23-1 Gd⁽³⁺⁾*(CH₂CH₂NCH₂COO)3(H₂NC₆H₄CHCH₂NCH₂COO)^(4-) = [Gd(CH₂CH₂NCH₂COO)3(H₂NC₆H₄CHCH₂NCH₂COO)]^(1-) 
• 107283-78-3 {gadolinium(III)(tetrakis(4-sulfonatophenyl)porphyrin)}^(3-) 

Downstream Products

• 777027-72-2 Cu(EDTA)^(2-) 

Relevant academic research and scientific papers

Ligands derived from C-aryl substituted derivatives of cyclen: Formation of kinetically unstable complexes with lanthanide(III) ions

The synthesis of C-aryl monosubstituted derivatives of 1,4,7,10-tetraazacyclododecane (cyclen) by metal templated reductive amination of triethylenetetramine with aryl glyoxals has been developed and shown to be widely applicable. Octadentate ligands deri